Why the study?
Does a heterozygous deficiency of protein C enhance focal arterial inflammation and thrombosis in response to an acute arterial hyperplasic challenge in mice?
Does a heterozygous deficiency of protein C enhance focal arterial inflammation and thrombosis in response to an acute arterial hyperplasic challenge in mice?
Protein C deficiency exacerbates arterial inflammation, thrombosis, and neointimal remodeling following acute arterial injury in a mouse model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in mice; leaves open relevance of protein C heterozygosity to human arterial injury or thrombosis.
Increased risk of thrombosis, with propitious conditions for fibrin deposition, along with upregulation of inflammation, are important factors that enhance plaque formation in atherosclerosis. Evidence supporting the role of anticoagulant protein C (PC) as an inflammatory agent has emerged, supplementing its well-known function as an anticoagulant. Thus, we sought to examine whether a PC deficiency would lead to an enhanced response to an acute arterial hyperplasic challenge. The presentation of early arterial inflammation was studied using a copper/silicone arterial cuff model of accelerated focal neointimal remodeling in mice with a heterozygous total deficiency of PC (PC+/-). Increased inflammation, cell proliferation, cell migration, fibrin elevation, and tissue necrosis were observed in the treated arteries of PC+/- mice, as compared to arteries of equally challenged age- and gender-matched WT mice. These results indicate that PC+/- mice subjected to this challenge displayed enhanced focal arterial inflammation and thrombosis, leading to larger neointimas and subsequent localized occlusion, as compared to their WT counterparts.
No takes yet. Share an insight, caveat, or question.
Ganopolsky et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: